176 related articles for article (PubMed ID: 31651790)
1. DSA Are Associated With More Graft Injury, More Fibrosis, and Upregulation of Rejection-associated Transcripts in Subclinical Rejection.
Höfer A; Jonigk D; Hartleben B; Verboom M; Hallensleben M; Hübscher SG; Manns MP; Jaeckel E; Taubert R
Transplantation; 2020 Mar; 104(3):551-561. PubMed ID: 31651790
[TBL] [Abstract][Full Text] [Related]
2. Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients.
Cousin VL; Rougemont AL; Rubbia-Brandt L; Wildhaber BE; Villard J; Ferrari-Lacraz S; McLin VA
Transplantation; 2020 Aug; 104(8):1633-1643. PubMed ID: 32732841
[TBL] [Abstract][Full Text] [Related]
3. Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts.
Baumann AK; Schlue J; Noyan F; Hardtke-Wolenski M; Lehner F; Barg-Hock H; Klempnauer J; Manns MP; Taubert R; Jaeckel E
Liver Transpl; 2016 Jul; 22(7):943-55. PubMed ID: 26929119
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies.
Höfer A; Jonigk D; Hartleben B; Verboom M; Hallensleben M; Manns MP; Jaeckel E; Taubert R
Sci Rep; 2020 Aug; 10(1):14242. PubMed ID: 32859929
[TBL] [Abstract][Full Text] [Related]
5. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
[TBL] [Abstract][Full Text] [Related]
6. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
[TBL] [Abstract][Full Text] [Related]
7. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.
Kelly D; Verkade HJ; Rajanayagam J; McKiernan P; Mazariegos G; Hübscher S
Liver Transpl; 2016 Nov; 22(11):1593-1602. PubMed ID: 27543906
[TBL] [Abstract][Full Text] [Related]
8. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy.
Schluckebier D; Cousin VL; Petit LM; Belli D; Wildhaber B; Rougemont AL; Villard J; Ferrari-Lacraz S; McLin VA
Pediatr Transplant; 2020 Feb; 24(1):e13611. PubMed ID: 31682057
[TBL] [Abstract][Full Text] [Related]
9. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
10. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.
Feng S; Bucuvalas JC; Demetris AJ; Burrell BE; Spain KM; Kanaparthi S; Magee JC; Ikle D; Lesniak A; Lozano JJ; Alonso EM; Bray RA; Bridges NE; Doo E; Gebel HM; Gupta NA; Himes RW; Jackson AM; Lobritto SJ; Mazariegos GV; Ng VL; Rand EB; Sherker AH; Sundaram S; Turmelle YP; Sanchez-Fueyo A
Gastroenterology; 2018 Dec; 155(6):1838-1851.e7. PubMed ID: 30144432
[TBL] [Abstract][Full Text] [Related]
12. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation.
Hruba P; Krejcik Z; Stranecky V; Maluskova J; Slatinska J; Gueler F; Gwinner W; Bräsen JH; Wohlfahrtova M; Parikova A; Osickova K; Fronek J; Seda O; Prefertusova L; Honsova E; Viklicky O
Transplantation; 2019 May; 103(5):909-917. PubMed ID: 30801516
[TBL] [Abstract][Full Text] [Related]
13. IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.
Jackson AM; Kanaparthi S; Burrell BE; Lucas DP; Vega RM; Demetris AJ; Feng S
Am J Transplant; 2020 Feb; 20(2):513-524. PubMed ID: 31561279
[TBL] [Abstract][Full Text] [Related]
14. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor repertoires within liver allografts are different to those in the peripheral blood.
Mederacke YS; Nienen M; Jarek M; Geffers R; Hupa-Breier K; Babel N; Reinke P; Mederacke I; Vondran FWR; Jonigk D; Wedemeyer H; Jaeckel E
J Hepatol; 2021 May; 74(5):1167-1175. PubMed ID: 33347951
[TBL] [Abstract][Full Text] [Related]
17. Obliterative portal venopathy: A histopathologic finding associated with chronic antibody-mediated rejection in pediatric liver allografts.
Guerra MR; Naini BV; Scapa JV; Reed EF; Busuttil RW; Cheng EY; Farmer DG; Vargas JH; Venick RS; McDiarmid SV; Wozniak LJ
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29363222
[TBL] [Abstract][Full Text] [Related]
18. Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
Sicard A; Meas-Yedid V; Rabeyrin M; Koenig A; Ducreux S; Dijoud F; Hervieu V; Badet L; Morelon E; Olivo-Marin JC; Dubois V; Thaunat O
Kidney Int; 2017 Jul; 92(1):214-226. PubMed ID: 28318622
[TBL] [Abstract][Full Text] [Related]
19. Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.
Jadlowiec CC; Morgan PE; Nehra AK; Hathcock MA; Kremers WK; Heimbach JK; Wiesner RH; Taner T
Liver Transpl; 2019 Mar; 25(3):425-435. PubMed ID: 30615251
[TBL] [Abstract][Full Text] [Related]
20. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
